The aim of our study was to investigate if common polymorphism SLC5A2 rs9934336 influences blood glucose levels and risk for macro and microvascular complications in Slovenian Type 2 diabetes patients even in the absence of treatment with SGLT2 inhibitors. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.